Michael Barnett
Overview
Explore the profile of Michael Barnett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
2632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Motyer A, Jackson S, Yang B, Harliwong I, Tian W, Shiu W, et al.
Nat Neurosci
. 2025 Mar;
PMID: 40038527
Neuroinflammation underpins neurodegeneration and clinical progression in multiple sclerosis (MS), but knowledge of processes linking these disease mechanisms remains incomplete. Here we investigated somatic single-nucleotide variants (sSNVs) in the genomes...
2.
Klistorner S, Barnett M, Parratt J, Yiannikas C, Wang C, Wang D, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(3):e200377.
PMID: 40020214
Background And Objectives: In this study, we examine the long-term changes in chronic lesion tissue (CLT) among patients with relapsing-remitting MS (RRMS), focusing on its impact on clinical and radiologic...
3.
Foong Y, Merlo D, Gresle M, Zhu C, Buzzard K, Lechner-Scott J, et al.
Ann Clin Transl Neurol
. 2025 Feb;
PMID: 40007145
Background: Cognitive impairment is one of the most common and debilitating symptoms of relapsing-remitting multiple sclerosis (RRMS). Digital cognitive biomarkers require less time and resources and are rapidly gaining popularity...
4.
Barnett M, Meister L, Rainey P
Science
. 2025 Feb;
387(6736):eadr2756.
PMID: 39977489
Evolvability-the capacity to generate adaptive variation-is a trait that can itself evolve through natural selection. However, the idea that mutation can become biased toward adaptive outcomes remains controversial. In this...
5.
Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari C, Lo Fermo S, et al.
Neurotherapeutics
. 2025 Feb;
22(2):e00552.
PMID: 39965993
Predicting long-term prognosis and choosing the appropriate therapeutic approach in patients with Multiple Sclerosis (MS) at the time of diagnosis is crucial in view of a personalized medicine. We investigated...
6.
Muller J, Sharmin S, Lorscheider J, Horakova D, Kubala Havrdova E, Eichau S, et al.
CNS Drugs
. 2025 Feb;
39(4):403-416.
PMID: 39953338
Background: In relapsing-remitting multiple sclerosis (RRMS), extended exposure to high-efficacy disease modifying therapy may increase the risk of side effects, compromise treatment adherence, and inflate medical costs. Treatment de-escalation, here...
7.
Foong Y, Merlo D, Gresle M, Zhu C, Buzzard K, Lechner-Scott J, et al.
Eur J Neurol
. 2024 Dec;
32(1):e70000.
PMID: 39714314
Background: Upper limb dysfunction is a common debilitating feature of relapsing-remitting multiple sclerosis (RRMS). We aimed to examine the longitudinal trajectory of the iPad®-based Manual Dexterity Test (MDT) and predictors...
8.
Lin S, Zheng J, Epstein A, Orav E, Barnett M, Grabowski D, et al.
J Am Geriatr Soc
. 2024 Aug;
72(11):3457-3466.
PMID: 39143027
Background: Although many healthcare settings have since returned to pre-pandemic levels of operation, long-term care (LTC) facilities have experienced extended and significant changes to operations, including unprecedented levels of short...
9.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, et al.
Mult Scler
. 2024 Aug;
30(9):1163-1175.
PMID: 39087208
Background: Comparisons between cladribine and other potent immunotherapies for multiple sclerosis (MS) are lacking. Objectives: To compare the effectiveness of cladribine against fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting MS....
10.
Barnett M, Persin M, Boynton H
Appl Neuropsychol Adult
. 2024 Jul;
:1-10.
PMID: 39067004
Nonsensical information increases task novelty, which makes it difficult to rely on previous learning and provides insight into the learning of new tasks. This study investigated procedural-based action scripts in...